Back
Stoke Therapeutics Stock Price Chart
Sponsored
STOK
Sponsored
AI DIVIDENDS: No. 1 Way to Collect Passive Income
Click here to get it for free.
Sell
27
STOK
Stoke Therapeutics
Last Price:
12.40
Seasonality Move:
11.82%
7 Day Trial
ALL ACCESS PASS
$
7
Investing Today: The Best Way To Grow A Small Account
In his free guide, expert Joe Duffy reveals... click here to read on...- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and STOK is experiencing slight selling pressure.
Stoke Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.29 | Buy |
20-day SMA: | 12.22 | Buy |
50-day SMA: | 13.37 | Sell |
200-day SMA: | 11.68 | Buy |
8-day EMA: | 12.34 | Buy |
20-day EMA: | 12.47 | Buy |
50-day EMA: | 13.03 | Sell |
200-day EMA: | 11.98 | Buy |
Stoke Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.25 | Sell |
Relative Strength Index (14 RSI): | 48.36 | Sell |
Chaikin Money Flow: | -21849 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.84 - 12.68) | Buy |
Bollinger Bands (100): | (12.64 - 15.12) | Sell |
Stoke Therapeutics Technical Analysis
Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Stoke Therapeutics Stock
Is Stoke Therapeutics Stock a Buy?
- Stoke Therapeutics share price is 12.51 while STOK 8-day simple moving average is 12.29, which is a Buy signal.
- The stock price of STOK is 12.51 while Stoke Therapeutics 20-day SMA is 12.22, which makes it a Buy.
- Stoke Therapeutics 50-day simple moving average is 13.37 while STOK share price is 12.51, making it a Sell technically.
- STOK stock price is 12.51 and Stoke Therapeutics 200-day simple moving average is 11.68, creating a Buy signal.
STOK Technical Analysis vs Fundamental Analysis
Sell
27
Stoke Therapeutics (STOK)
is a Sell
Is Stoke Therapeutics a Buy or a Sell?
-
Stoke Therapeutics stock is rated a Sell
The current Stoke Therapeutics [STOK] share price is $12.51. The Score for STOK is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
Stoke Therapeutics Stock Info
Market Cap:
658.62M
Price in USD:
12.51
Share Volume:
128.43K
Stoke Therapeutics 52-Week Range
52-Week High:
17.58
52-Week Low:
3.46
Sell
27
Stoke Therapeutics (STOK)
is a Sell
Stoke Therapeutics Share Price Forecast
-
What is the Stoke Therapeutics stock price today?
The Stoke Therapeutics stock price is 12.51 USD today. -
Will STOK stock go up or go down?
Stoke Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Stoke Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Stoke Therapeutics is overvalued.
Is Stoke Therapeutics Stock a Buy?
- Stoke Therapeutics share price is 12.51 while STOK 8-day exponential moving average is 12.34, which is a Buy signal.
- The stock price of STOK is 12.51 while Stoke Therapeutics 20-day EMA is 12.47, which makes it a Buy.
- Stoke Therapeutics 50-day exponential moving average is 13.03 while STOK share price is 12.51, making it a Sell technically.
- STOK stock price is 12.51 and Stoke Therapeutics 200-day simple moving average is 11.98, creating a Buy signal.
Fundamental Analysis of Stoke Therapeutics
Is Stoke Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and a decrease next year of $0.39 per share.
Technical Analysis of Stoke Therapeutics
Should I short Stoke Therapeutics stock?
- STOK Moving Average Covergence Divergence (MACD) indicator is -0.25, suggesting Stoke Therapeutics is a Sell
- Stoke Therapeutics Relative Strength Index (RSI) is 48.36, which suggest Stoke Therapeutics is oversold
- The Bollinger Bands (25) for Stoke Therapeutics is (11.84 - 12.68), which suggest Stoke Therapeutics is a Sell
- The Bollinger Bands (100) for Stoke Therapeutics is (12.64 - 15.12), which suggest Stoke Therapeutics is a Sell
* Stoke Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.